These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10964677)

  • 21. 3D-QSAR and docking studies of aldehyde inhibitors of human cathepsin K.
    Pan X; Tan N; Zeng G; Han H; Huang H
    Bioorg Med Chem; 2006 Apr; 14(8):2771-8. PubMed ID: 16377193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis for reversible and irreversible inhibition of human cathepsin L by their respective dipeptidyl glyoxal and diazomethylketone inhibitors.
    Shenoy RT; Sivaraman J
    J Struct Biol; 2011 Jan; 173(1):14-9. PubMed ID: 20850545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent and selective ketoamide-based inhibitors of cysteine protease, cathepsin K.
    Tavares FX; Deaton DN; Miller AB; Miller LR; Wright LL; Zhou HQ
    J Med Chem; 2004 Oct; 47(21):5049-56. PubMed ID: 15456248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins.
    Sasaki T; Kishi M; Saito M; Tanaka T; Higuchi N; Kominami E; Katunuma N; Murachi T
    J Enzyme Inhib; 1990; 3(3):195-201. PubMed ID: 2079636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irreversible inhibition of human cathepsins B, L, S and K by hypervalent tellurium compounds.
    Cunha RL; Gouvêa IE; Feitosa GP; Alves MF; Brömme D; Comasseto JV; Tersariol IL; Juliano L
    Biol Chem; 2009 Nov; 390(11):1205-12. PubMed ID: 19663682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitors.
    Tully DC; Liu H; Chatterjee AK; Alper PB; Williams JA; Roberts MJ; Mutnick D; Woodmansee DH; Hollenbeck T; Gordon P; Chang J; Tuntland T; Tumanut C; Li J; Harris JL; Karanewsky DS
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5107-11. PubMed ID: 16876407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-Cyano-pyrimidines: a new chemotype for inhibitors of the cysteine protease cathepsin K.
    Altmann E; Aichholz R; Betschart C; Buhl T; Green J; Irie O; Teno N; Lattmann R; Tintelnot-Blomley M; Missbach M
    J Med Chem; 2007 Feb; 50(4):591-4. PubMed ID: 17256925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a specific inhibitor for the placental protease, cathepsin P.
    Hassanein M; Xue F; Seto CT; Mason RW
    Arch Biochem Biophys; 2007 Aug; 464(2):288-94. PubMed ID: 17531191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cathepsin S inhibitors: WO2010070615.
    Löser R
    Expert Opin Ther Pat; 2011 Apr; 21(4):585-91. PubMed ID: 21247364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors.
    Cai J; Bennett DJ; Rankovic Z; Dempster M; Fradera X; Gillespie J; Cumming I; Finlay W; Baugh M; Boucharens S; Bruin J; Cameron KS; Hamilton W; Kerr J; Kinghorn E; McGarry G; Robinson J; Scullion P; Uitdehaag JC; van Zeeland M; Potin D; Saniere L; Fouquet A; Chevallier F; Deronzier H; Dorleans C; Nicolai E
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4447-50. PubMed ID: 20594841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent and selective P2-P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1', P1, and/or P3 substitutions.
    Barrett DG; Catalano JG; Deaton DN; Hassell AM; Long ST; Miller AB; Miller LR; Shewchuk LM; Wells-Knecht KJ; Willard DH; Wright LL
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4897-902. PubMed ID: 15341947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?
    Adkison KK; Barrett DG; Deaton DN; Gampe RT; Hassell AM; Long ST; McFadyen RB; Miller AB; Miller LR; Payne JA; Shewchuk LM; Wells-Knecht KJ; Willard DH; Wright LL
    Bioorg Med Chem Lett; 2006 Feb; 16(4):978-83. PubMed ID: 16290936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational design of potent and selective NH-linked aryl/heteroaryl cathepsin K inhibitors.
    Robichaud J; Bayly C; Oballa R; Prasit P; Mellon C; Falgueyret JP; Percival MD; Wesolowski G; Rodan SB
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4291-5. PubMed ID: 15261289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3,4-disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity.
    Setti EL; Davis D; Janc JW; Jeffery DA; Cheung H; Yu W
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1529-34. PubMed ID: 15713422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rhenium inhibitors of cathepsin B (ReO(SYS)X (where Y = S, py; X = Cl, Br, SPhOMe-p)): Synthesis and mechanism of inhibition.
    Mosi R; Baird IR; Cox J; Anastassov V; Cameron B; Skerlj RT; Fricker SP
    J Med Chem; 2006 Aug; 49(17):5262-72. PubMed ID: 16913715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of papain-like cysteine proteases with dipeptide-derived nitriles.
    Löser R; Schilling K; Dimmig E; Gütschow M
    J Med Chem; 2005 Dec; 48(24):7688-707. PubMed ID: 16302809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, biological evaluation and molecular modelling of N-heterocyclic dipeptide aldehydes as selective calpain inhibitors.
    Jones MA; Morton JD; Coxon JM; McNabb SB; Lee HY; Aitken SG; Mehrtens JM; Robertson LJ; Neffe AT; Miyamoto S; Bickerstaffe R; Gately K; Wood JM; Abell AD
    Bioorg Med Chem; 2008 Jul; 16(14):6911-23. PubMed ID: 18571418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and identification of a protease inhibitor from glassfish (Liparis tanakai) eggs.
    Ustadi U; Kim KY; Kim SM
    J Agric Food Chem; 2005 Oct; 53(20):7667-72. PubMed ID: 16190614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketoamide-based inhibitors of cysteine protease, cathepsin K: P3 modifications.
    Tavares FX; Deaton DN; Miller LR; Wright LL
    J Med Chem; 2004 Oct; 47(21):5057-68. PubMed ID: 15456249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly selective aza-nitrile inhibitors for cathepsin K, structural optimization and molecular modeling.
    Yuan XY; Fu DY; Ren XF; Fang X; Wang L; Zou S; Wu Y
    Org Biomol Chem; 2013 Sep; 11(35):5847-52. PubMed ID: 23900712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.